Notes

MORNING BID 🔸 Nvidia ( $NVDA): • Q4 adj. EPS $0.89 (est. $0.84) • revs $39.33B (est. $38.05B) • Data center revs $35.6B (+93%) • Auto $570M (+103%) • Gaming $2.5B (-11%) • Q1 revs $43B ±2% (est. $41.78B). 🔸 Amazon ( $AMZN): Debuted Ocelot, its first quantum computing chip. 🔸 Snowflake ( $SNOW): • Q4 EPS $0.30 (est. $0.18) • revs $986.8M (+28%, est. $956.26M) • Q1 product revs guidance $955M-$960M (est. $962.6M); expanded Microsoft partnership. 🔸 Salesforce ( $CRM) • Q4 adj. EPS $2.78 (est. $2.61) • revs $9.99B (missed est. $10.04B) • Q1 guidance below consensus: EPS $2.53-$2.55, revs $9.71B-$9.76B. 🔸 https://t.co/dPTowbRrks ( $AI): • Q3 EPS -$0.12 (est. -$0.25) • revs $98.8M (+26%, est. $98.1M) • Q4 revs guidance $103.6M-$113.6M (est. $108.6M). 🔸 Magnite ( $MGNI) Q4 adj. EPS $0.34 (est. $0.36) revs $194M (est. $184.3M) FY adj. EBITDA guidance mid-teens % (est. +12.8%). 🔸 Nutanix ( $NTNX) Q2 adj. EPS $0.56 (est. $0.47) revs $654.7M (est. $641.86M) Q3 revs guidance $620M-$630M (est. $594.39M). 🔸 eBay ( $EBAY) Q4 adj. EPS $1.25 (est. $1.20) revs $2.6B (est. $2.58B) GMV $19.3B (+4%) Q1 adj. EPS guidance $1.32-$1.36 (est. $1.33) revs $2.52B-$2.56B (est. $2.59B) GMV $18.3B-$18.6B. 🔸 Paramount ( $PARA): Q4 revs $7.98B (est. $8.1B); Paramount+ added 5.6M subs (est. 2.58M). 🔸 Pure Storage ( $PSTG): Q4 EPS $0.45 (est. $0.42), revs $879.8M (est. $869.19M); FY revs guidance $3.515B (est. $3.52B). 🔸 Synopsys ( $SNPS): Q1 EPS $3.03 (est. $2.79), revs $1.46B (est. $1.45B); FY EPS guidance $14.88-$14.96 (est. $14.89). 🔸 TaskUs ( $TASK): Q4 EPS $0.31 (est. $0.34), revs $274.2M (est. $268.8M); FY adj. EBITDA margin ~21%. 🔸 TKO Group ( $TKO): Q4 EPS $0.28 (est. $0.21), revs $642.2M (est. $604M); FY adj. EBITDA $1.35B-$1.39B (FY24: $1.25B). 🔸 Norwegian Cruise Line ( $NCLH): Q4 adj. EPS $0.26 (est. $0.11), revs $2.11B (in line); Q1 Net Yield expected to rise ~0.5% y/y (constant currency). 🔸 Urban Outfitters ( $URBN): Q4 adj. EPS $1.04 (est. $0.94), revs $1.64B (+10%, est. $1.61B); Retail segment sales +6.3%, driven by digital and store growth. 🔸 Agilent ( $A): Q1 adj. EPS $1.31 (est. $1.27), revs $1.68B (est. $1.67B); Q2 guidance below estimates; FY25 revs cut to $6.68B-$6.76B (est. $6.82B). 🔸 CareDx ( $CDNA): Q4 adj. EPS $0.18 (est. $0.15), revs $86.6M (est. $84.56M); FY25 revs guidance $365M-$375M (est. $370.02M); Testing services revs +37% y/y. 🔸 Catalyst Pharma ( $CPRX): Q4 EPS $0.70 (est. $0.55), revs $141.8M (+28%, est. $134.2M); FY revs guidance $545M-$565M (est. $558.1M). 🔸 Outset Medical ( $OM): Filed $100M mixed securities shelf. 🔸 Sarepta ( $SRPT): Q4 adj. EPS $1.90 (in line), revs $658.4M (est. $627.58M). 🔸 Teladoc ( $TDOC): Q4 EPS -$0.28 (est. -$0.24), revs $640.49M (est. $639.55M); FY revs and EBITDA guidance below estimates. 🔸 Tandem Diabetes ( $TNDM): Q4 EPS $0.01 (est. -$0.23), revs $282.6M (est. $251.98M); FY revs guidance $997M-$1.007B (est. $1.008B). 🔸 Universal Health ( $UHS): Q4 adj. EPS $4.92 (est. $4.18), revs $4.11B (est. $4.01B); FY revs and EBITDA guidance above estimates.
$NVDA
+5.46%
$AMZN $SNOW $CRM $AI
+7.44%
$MGNI $NTNX $EBAY $PARA $PSTG $SNPS $TASK $TKO
+1.37%
$NCLH $URBN $A $CDNA $CPRX $OM
-0.49%
$SRPT $TDOC $TNDM $UHS
MORNING BID 🔸 $ACMR: Raises 2024 revenue forecast to $755M-$770M from $725M-$745M; sees 2025 at $850M-$950M vs. consensus $902.95M. 🔸 $APLD: Shares up 30% after Macquarie's $5B investment for 15% stake in AI data centers. 🔸 $AVGO: Secures $7.5B five-year credit facility. 🔸 $IAC: To spin off $ANGI stake to shareholders; Joey Levin steps down as CEO. 🔸 $TTAN: Q3 revenue $199.3M; Q4 expected at $199M-$201M vs. consensus $193.58M; FY25 revenue projected at $761.6M-$763.6M vs. consensus $755.37M. 🔸 $DHR: Q4 revenue expected to rise by low single digits year-over-year. 🔸 $INGN: Q4 revenue forecast at $79.0M-$80.0M, above $73.9M estimate; FY24 revenue guidance raised to $334.5M-$335.5M from $329M-$331M, vs. $329.62M consensus. 🔸 $KIDS: Q4 revenue at $52.7M vs. $50.73M estimate; FY25 revenue guidance $235-242M vs. $239.95M estimate, adjusted EBITDA $15-17M vs. $20.14M forecast. 🔸 $RGNX: Stock up after deal with Nippon Shinyaku for gene therapies; $110M upfront and potential $700M in milestones. 🔸 $TDOC: New partnership with $AMZN to broaden access to chronic care programs. 🔸 $RILY: Shares rise after Q2 2024 report showing a $14.35 per share net loss, delayed due to Franchise Group issues; expects normal filing schedule in 2025. 🔸 $AB: AUM fell to $792B in December 2024 from $813B, a 2.6% drop due to market and outflow issues. 🔸 $IVZ: AUM dropped to $1,846B, down 0.6% with $12.6B in net long-term inflows but $42B reduction from market returns. 🔸 $VRTS: Total client assets at $177.3B in December 2024, down due to outflows and market performance. 🔸 $URI: Acquiring $HEES for $92/share, valuing the deal at $4.8B including debt. Insurance Industry: LA wildfires might cost insurers over $30B, with significant damage from Palisades and Eaton fires. 🔸 $AVAV: Secures $55.3M order for Switchblade Systems under U.S. Army's LUS program. 🔸 $CE: Upgraded to Buy from Underperform by Bank of America on valuation. 🔸 $FANG: Q4 unhedged prices at $69.48/bbl oil, $0.48/mcf gas, $19.27/bbl NGLs; hedged prices at $68.72/bbl oil, $0.82/mcf gas, $19.27/bbl NGLs. 🔸 $WAB: Agrees to purchase Evident's inspection tech division for $1.78B. 🔸 $KBH: Q4 EPS $2.52 vs. $2.45 est., revenue $1.999B vs. $2.008B est.; FY25 housing revenue guidance $7.00-7.50B, avg selling price $488-498K. 🔸 $NOMD: 2025 organic revenue growth expected at 1%-3%; confident in meeting 2024 guidance. 🔸 $SIG: Q4 adj. operating income forecast at $337M-$347M, below previous $397M-$427M; sales expected at $2.32B-$2.34B, under prior $2.38B-$2.46B. 🔸 $ADM: Downgraded to Underperform from Neutral by Bank America. 🔸 $LVS: Downgraded to Equal Weight from Overweight by Morgan Stanley.
$ACMR $APLD $AVGO $IAC $ANGI $TTAN $DHR $INGN $KIDS $RGNX $TDOC $AMZN $RILY $AB
-6.54%
$IVZ $VRTS $URI $HEES $AVAV $CE $FANG $WAB $KBH $NOMD $SIG $ADM $LVS
Sign in to Coinnx